Survival Advantage for TAVR Over Surgery in High-Risk Patients
Transcatheter aortic valve replacement (TAVR), which has been slowly and cautiously entering the clinical arena, will probably get a big boost from a new trial showing a significant mortality advtange...
View ArticleTAVR: Are You Impressed Now?
Interventionalist Ajay Kirtane offers his perspective on the new randomized trial comparing transcatheter (CoreValve) with surgical aortic valve replacement. The post TAVR: Are You Impressed Now?...
View ArticleFirst TAVR Comparison Trial Favors Sapien XT Over CoreValve
With two devices now approved for transcatheter aortic valve replacement (TAVR), the marketing battle has begun to win the hearts and minds of cardiologists. On Saturday at the ACC, Medtronic gained...
View ArticleTaking Patient-Centeredness to the Next Level at ACC.14
A fellow discusses an interesting lecture approach at ACC.14.The post Taking Patient-Centeredness to the Next Level at ACC.14 appeared first on CardioExchange.
View ArticleThe CoreValve Trial: What Do You Say to Your Patients?
Harlan Krumholz presents a scenario based on the CoreValve trial and asks, "What do you say to your patient?"The post The CoreValve Trial: What Do You Say to Your Patients? appeared first on...
View ArticleFDA Approves Second-Generation Heart Valve from Edwards Lifesciences
The next phase of the burgeoning and rapidly maturing transcatheter aortic valve replacement (TAVR) market has begun. Edwards Lifesciences announced on Monday afternoon that the FDA had approved its...
View ArticleNo Difference in Survival Found for Different Aortic Valve Prostheses
A new study published in JAMA suggests that younger patients who need aortic valve replacement (AVR) may now be more eligible to receive bioprosthetic valves. Each year about 50,000 people in the U.S....
View ArticleAortic Valve Surgery for Nonagenarians
As people continue to live longer physicians are increasingly confronted with very elderly patients who have serious conditions that might benefit from surgery but who are at high risk for surgical...
View ArticleFirst Good Look at TAVR in The Real World
Transcatheter aortic valve replacement (TAVR) is one of the most important advances in cardiovascular medicine in recent years. Although it is associated with significant risks, TAVR can offer some...
View ArticleEncouraging 5-Year Results for TAVR
The publication five years ago of the two-part PARTNER trial brought a major change to the treatment of aortic valve replacement. The trial demonstrated that transcatheter aortic valve replacement...
View Article
More Pages to Explore .....